Results

Total Results: 1,430 records

Showing results for "continue".

221. Diagnosis of Attention-Deficit/Hyperactivity Disorder in Adults: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hyperactivity-disorder-protocol-amendment.pdf
     January 08, 2025 - Diagnosis of Attention-Deficit/Hyperactivity Disorder in Adults: A Systematic Review EPC Protocol Version 21, 3/4/2024 Evidence-based Practice Center Systematic Review Protocol Project Title: Diagnosis of Attention-Deficit/Hyperactivity Disorder in Adults: A Systematic Review Initial public…

222. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hyperactivity-disorder-protocol.pdf
     November 10, 2024 - Evidence-based Practice Center Systematic Review Protocol Evidence-based Practice Center Systematic Review Protocol Project Title: Diagnosis of Attention-Deficit/Hyperactivity Disorder in Adults: A Systematic Review I. Background and Objectives for the Systematic Review Attention-deficit/hyperacti…

223. S13 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s13.pdf
     October 01, 2007 - Further, the selection of dose over time, and even the decision to continue or discontinue the drug,

224. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_2012-12-10.pdf
     January 01, 2012 - The company also intends to continue enrolling patients in its physician utilization study of the Iluvien … completed phase III trials (FAME ™ studies) to address FDA concerns. 38 The company also intends to continue … Patients could continue for an additional 24 weeks for a total of 48 weeks of treatment.

225. Ch 4-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_4-user-guide-to-ocer_130129.pdf
     January 01, 2010 - Continued exposure to oral corticosteroids may continue to increase the risk of fracture associated

226. Pharmacotherapy for Adults With Alcohol-Use Disorders in Outpatient Settings: Systematic Review Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/alcohol-pharma-final-protocol.pdf
     January 01, 2023 - pharmacotherapies.3 Definitions of unhealthy alcohol use (sometimes previously referred to as alcohol misuse)4 continue … other medical and psychiatric problems.13 Treatments for Alcohol-Use Disorders Treatments for AUDs continue

227. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1406.pdf
     September 26, 2014 - Diabetes Mellitus AHRQ Healthcare Horizon Scanning System – Potential High-Impact Interventions Report Priority Area 07: Diabetes Mellitus Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 www.ahrq.gov …

228. Osteoporosis-Bone-Fracture Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_executive.pdf
     March 01, 2012 - Even patients who continue to lose BMD during therapy have had statistically significant benefits in

229. S89 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s89.pdf
     October 01, 2007 - Surveillance for the rarer outcomes of GBS and thrombocytopenia is expected to continue until 230,000

230. Development of Harmonized Outcome Measures for Use in Patient Registries and Clinical Practice: Methods and Lessons Learned (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-standardized-library.pdf
     February 01, 2019 - It is recommended that a 18 continued phased roll out of clinical areas continue, and that a more

231. Disposition of Comments Report for Technical Brief 15 Transition Care for Children With Special Health Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/children-special-needs-transition_disposition-comments.pdf
     June 17, 2014 - Commentator & Affiliation Section Comment Response Reviewer 5 (TEP) Background So we have continue … potential through the provision of high-quality, developmentally appropriate healthcare services that continue … potential through the provision of high-quality, developmentally appropriate health care services that continue … potential through the provision of high- quality, developmentally appropriate health care services that continue … adult health care providers; the transition to adulthood in all of its aspects including health will continue

232. Phenylketonuria Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/phenylketonuria_executive.pdf
     February 01, 2012 - treatment of PKU under the stipulation that studies regarding the drug’s efficacy and long-term safety continue … Research should continue to include RCTs, but prospective cohort studies that may have the potential

233. Grades-Predictive-Values White-Paper-2015 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/grades-predictive-values_white-paper-2015.pdf
     January 01, 2015 - Research White Paper Comparison of Effects as Evidence Evolves From Single Trials to High-Quality Bodies of Evidence Research White Paper Comparison of Effects as Evidence Evolves From Single Trials to High-Quality Bodies of Evidence Prepared for: Agency for Healthc…

234. Peripheral Nerve Blocks for Postoperative Pain Management in Cardiothoracic Surgery (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/peripheral-nerve-block-protocol.pdf
     November 18, 2023 - Peripheral Nerve Blocks for Postoperative Pain Management in Cardiothoracic Surgery Evidence-based Practice Center Systematic Review Protocol Project Title: Peripheral Nerve Blocks for Postoperative Pain Management in Cardiothoracic Surgery I. Background and Objectives for the Systematic Review Millio…

235. Assessing the Risk of Bias of Individual Studies in Systematic Reviews of Health Care Interventions (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-bias-individual-studies_methods.pdf
     March 01, 2012 - workgroup consensus: as greater evidence accumulates in this methodological area, our standards will continue … overlap with, or are distinct from risk-of-bias assessment of individual studies, some review groups continue … standards on reporting seek to improve reporting of study design and conduct,25-29 EPC review teams continue … if composite outcomes are presented without the individual component outcomes.17,p 409 Methods continue … studies.42 As methods on identifying and weighing the likely effect of selective outcome reporting continue

236. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-insulin_executive.pdf
     September 01, 2008 - Layout 1 Background and Key Questions Although oral antidiabetic agents are used as first-line agents in patients with type 2 diabetes, insulin is required in a significant number of patients at some stage during the management of diabetes to maintain optimal glycemic control. Insulin use has been suggested as a fir…

237. Alcohol-Misuse-Drug-Therapy Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy_executive.pdf
     January 27, 2012 - other medical and psychiatric problems.9 Treatments for Alcohol-Use Disorders Treatments for AUDs continue

238. Contrast-Induced Nephropathy (CIN): Current State of the Evidence on Contrast Media and Prevention of CIN (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/nephropathy-contrast-induced_clinician.pdf
     August 01, 2016 - Contrast-Induced Nephropathy (CIN): Current State of the Evidence on Contrast Media and Prevention of CIN Focus of This Summary This is a summary of two systematic reviews. One review evaluated the evidence regarding the comparative effects of different contrast media in patients requiring diagnostic imaging studies…

239. Hepatitis-C-Screening Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-screening_executive.pdf
     November 01, 2012 - at 1.0 million in 2020, though rates of hepatic decompensation and liver cancer are expected to continue … vary depending on the population studied and criteria used to determine treatment eligibility, which continue … vary depending on the population studied and criteria used to determine treatment eligibility, which continue … Research Gaps Significant research gaps continue to limit full understanding of the benefits and harms

240. Osheroff_Respondent_Ebell 2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/use_of_handheld_osheroff_respondent.pdf
     January 01, 2009 - Osheroff_Respondent_Ebell 2   Source:    Eisenberg  Center  Conference  Series  2009,  Translating  Information  Into  Action:  Improving  Quality  of   Care  Through  Interactive  Media,  Effective  Health  Care  Program  Web  site   (http://www.effectivehealthcare…